FReSH-83099-en
Study titleStudy titleeeedada
Study acronym
| Name | Country code |
|---|---|
| France | fr |
| Åland islands | ax |
Study summary *
['Clinical data','Paraclinical data (non-biological)','Paraclinical data (non-biological) : Imaging','Biological data','Environmental / exposure data','Behavioral data','Economic data','Participant-reported health data','Other']
Individus
| Topic | Vocabulary |
|---|---|
| Addiction medicine | health theme |
| Allergology | health theme |
| Venereology | health theme |
| Other | health theme |
| Ramifenazone | cim-11 |
| Ramipril | cim-11 |
| Ramucirumab | cim-11 |
| Socio-demographic and economic determinants | health determinant |
| Socio-demographic and economic determinants: Employment | health determinant |
| Environmental determinants | health determinant |
| Environmental determinants: Air quality | health determinant |
| Healthcare system determinants | health determinant |
| Healthcare system determinants: Access to care | health determinant |
| Behavioral determinants | health determinant |
| Behavioral determinants: Addiction | health determinant |
| Biological determinants | health determinant |
| Biological determinants: Genetic predisposition | health determinant |
| Other | health determinant |
| Other medical specialty, details | other health theme |
| Other determinants, details | other determinant |
['Auvergne Rhône-Alpes','Bourgogne Franche-Comté','Pays de la Loire','Provence - Alpes - Côte d'Azur']
{
"level_sex_clusion_I": [
{
"concept": {
"vocab": "MeSH",
"vocabURI": ""
},
"value": "Other"
}
],
"level_age_clusion_I": [
{
"concept": {
"vocab": "MeSH",
"vocabURI": ""
},
"value": "Prenatal"
},
{
"concept": {
"vocab": "MeSH",
"vocabURI": "D007231"
},
"value": "Infant, Newborn (birth to 28 days)"
},
{
"concept": {
"vocab": "MeSH",
"vocabURI": "D000368"
},
"value": "Aged (65 to 79 years)"
},
{
"concept": {
"vocab": "MeSH",
"vocabURI": "D000369"
},
"value": "Aged, 80 and over (80 years and more)"
}
],
"level_type_clusion_I": "Other",
"level_type_clusion_other": "Other population type, details",
"clusion_I": "Inclusion Criteri",
"clusion_E": "Exclusion Criteria"
}
| Name |
|---|
| First name of the principal investigator111111111;LAST NAME OF THE PRINCIPAL INVESTIGATOR1111111111 |
| First name of the principal investigator 2222222;LAST NAME OF THE PRINCIPAL INVESTIGATOR 22222222222 |
| First name of the principal investigator;FIRST NAME OF THE PRINCIPAL INVESTIGATOR |
| Name | Role |
|---|---|
| AEPEI (ASSOCIATION POUR L'ETUDE ET LA PREVENTION DES L'ENDOCARDITE INFECTIEUSE) | sponsor |
| CENTRE PSYCHOTHERAPIQUE DE NANCY (CPN) | sponsor |
| AG2R AGIRC-ARRCO (UGRR) | sponsor |
| Name |
|---|
| AG2R AGIRC-ARRCO (UGRR) |
| Name |
|---|
| First name of the team leade1111111111;LAST NAME OF THE TEAM LEADE111111111111 |
| AEPEI (ASSOCIATION POUR L'ETUDE ET LA PREVENTION DES L'ENDOCARDITE INFECTIEUSE) |
| First name of the team leader2222222222;LAST NAME OF THE TEAM LEADER22222222222 |
| ABBOTT FRANCE |
| Collaboration(s) involved, detaiCollaboration(s) involved, detaiCollaboration(s) involved, detaiCollaboration(s) involved, detaiCollaboration(s) involved, detaiCollaboration(s) involved, detaiCollaboration(s) involved, detaiCollaboration(s) involved, detaiCollaboration(s) involved, detai |
| Agency name |
|---|
| ANSM |
| CNIL |
| CESREES |
| CPP |
| Other |
['Administrative database (employees, pupils, students, etc.)','Disease and death registry','Other']
['{"concept":{"vocab":"CESSDA","vocabURI":"TotalUniverseCompleteEnumeration"},"value":"Complete enumeration (including consecutive recruitment)"}','{"concept":{"vocab":"CESSDA","vocabURI":"Probability"},"value":"Probability"}','{"concept":{"vocab":"CESSDA","vocabURI":"Probability.SimpleRandom"},"value":"Probability: Simple random"}','{"concept":{"vocab":"CESSDA","vocabURI":"Nonprobability"},"value":"Non-probability"}','{"concept":{"vocab":"CESSDA","vocabURI":"Nonprobability.Availability"},"value":"Non-probability: Availability (convenience or opportunity sampling)"}','{"concept":{"vocab":"CESSDA","vocabURI":"MixedProbabilityNonprobability"},"value":"Mixed probability and non-probability"}','{"concept":{"vocab":"CESSDA","vocabURI":"Other"},"value":"Other"}']
dzadzadzad
Observational Study
| Start | End |
|---|---|
| 2000-02-12 | 2009-02-12 |
Retrospective longitudinal
jyrjrjrtjt
| Standard |
|---|
| ['zdadzadzad','zadazdazdadazd'] |
['zadazdzadad','dzadazdzadzad']
eeeeeeeeeeeeeeeeeeee
dzadzazzzzzzzzzzzzz
eeeeeeeeeeeeeeeee
| Name | |
|---|---|
| zdadzadzadzad;DZADAZDAZDZAD | rami.kolsi@impactgroup.tech |
| Confidentiality declaration text |
|---|
| rrrrrrrrrrrrrrrrrrrrrrr |
aaaaaaaaaaaaaaaa
zadadzad
dzadzad
{"extLink":{"title":"COAR","uri":"http://purl.org/coar/access_right/c_14cb"},"value":"Metadata-only access"}
| Indicate if special permissions are required to access a resource | Special permissions description |
|---|---|
| Yes | dzadadzad |
zzzzzzzzzzzzz
| Name | |
|---|---|
| First name of the principal investigator;LAST NAME OF THE PRINCIPAL INVESTIGATOR | kine4@impact-dev.tn |
| First name of the principal investigator111111111;LAST NAME OF THE PRINCIPAL INVESTIGATOR1111111111 | kine4@impact-dev.tn |
| First name of the principal investigator 2222222;LAST NAME OF THE PRINCIPAL INVESTIGATOR 22222222222 | kine7@impact-dev.tn |
| First name of the team leade1111111111;LAST NAME OF THE TEAM LEADE111111111111 | dir1@impact-dev.tn |
| First name of the team leader2222222222;LAST NAME OF THE TEAM LEADER22222222222 | rami.kolsi@impactgroup.tech |
| First name of the principal investigator;FIRST NAME OF THE PRINCIPAL INVESTIGATOR | kine2@impact-dev.tn |
FReSH-83099-en
| Name |
|---|
| kolsi Rami |